ORIX

Recent news

• IX Biopharma Rides DoD-Backed Wafermine Push and U.S. Expansion Strategy
  TipRanks · 2026/9/23
• Company notice
  4: Netskope | 4: Statement of changes in beneficial ownership of securities-10% Owner Lightspeed Venture Partners IX, L.P.
  SEC · 2026/7/10
• Company notice
  4: Boundless Bio | 4: Statement of changes in beneficial ownership of securities-10% Owner ARCH Venture Fund IX, L.P.
  SEC · 2026/7/7
• IX Biopharma Advances Wafermine as U.S. Opens Rare Military Emergency Use Pathway
  TipRanks · 2026/9/7
• Phillip Securities Remains a Buy on IX Biopharma Ltd. (42C)
  TipRanks · 2026/9/9
• Company notice
  ORIX: (Progress of Matters for Disclosure) Notice Regarding Transfer of Equity Interest (change in subsidiary): IX NTI Holdings (U.S. PE Investment: NC)
  JPX · 2026/6/30
• AXP Energy Exits Syrian Block IX Farm-In to Refocus on U.S. Operations
  TipRanks · 2026/8/31
• Company notice
  IX Biopharma: Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)-Cessation of Substantial Shareholder - Anson Properties Pte. Ltd.
  SGX · 2026/9/10
• Rating change
  BofA Securities Maintains ORIX(IX.US) With Hold Rating
  Market Newswire · 2026/8/10
• Analyst Maintains Buy on IX Biopharma, Sees Post-FY26 Transition Driving Strong FY27+ Rebound and Keeps DCF-Based S$1.00 Target Price
  TipRanks · 2026/9/1
• Company notice
  Netskope | 4: Statement of changes in beneficial ownership of securities-10% Owner Lightspeed Venture Partners IX, L.P.
  SEC · 2026/9/15
• Rating change
  BofA Securities Initiates ORIX(IX.US) With Hold Rating
  Market Newswire · 2024/11/12

Headlines are aggregated automatically and are not independently verified or edited by our team.